Actual Medicinal Product (AMP) -
Kenalog Intra-articular / Intramuscular 40mg/1ml suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd)
Name Details
Current Name
Kenalog Intra-articular / Intramuscular 40mg/1ml suspension for injection vials
|
Start Date
15-06-2004
|
End Date
|
Previous Name
Kenalog Intra-articular / Intramuscular 40mg/ml injection 1ml vials
|
Start Date
27-11-2002
|
End Date
14-06-2004
|
|
Abbreviated Name
Kenalog Intra-articular / Intramuscular 40mg/1ml inj vials
|
Start Date
01-05-2009
|
|
Kenalog Intra-articular/Intramuscular 40mg/1ml inj vl |
Previous Start Date
15-09-2004
|
Previous End Date
30-04-2009
|
Summary
- Licensed Route
- Intraarticular, Intramuscular
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
Codes
BNF |
Previous BNF
10010202
|
Start Date
06-06-2005
|
End Date
03-04-2022
|
Previous BNF
01050000
|
Start Date
06-06-2005
|
End Date
03-04-2022
|
Previous BNF
03020000
|
Start Date
06-06-2005
|
End Date
03-04-2022
|
Previous BNF
06030200
|
Start Date
06-06-2005
|
End Date
03-04-2022
|
Previous BNF
13040000
|
Start Date
06-06-2005
|
End Date
03-04-2022
|
Previous BNF
13050000
|
Start Date
06-06-2005
|
End Date
03-04-2022
|
Previous BNF
09010300
|
Start Date
06-06-2005
|
End Date
03-04-2022
|
Previous BNF
09010400
|
Start Date
06-06-2005
|
End Date
03-04-2022
|
Previous BNF
08020200
|
Start Date
06-06-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
306011000001103 |
27-11-2002 |
|
Actual Medicinal Product Pack (AMPP) Information